Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureMeng Chieh Yang, Nichawadee Sandech, Sucheewin Krobthong, Likit Rangsirattanakul, Wisuit Pradidarcheep, Arnatchai Maiuthed
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Hallmarks of cancer: the next generation
10.1016/j.cell.2011.02.013 · 2011
Understanding the Warburg effect: the metabolic requirements of cell proliferation
10.1126/science.1160809 · 2009
Lipid metabolism in cancer cells under metabolic stress
10.1038/s41416-019-0451-4 · 2019
Lipid metabolism in cancer cells: its role in hepatocellular carcinoma progression and therapeutic resistance
10.1097/hc9.0000000000000837 · 2025
Lipid metabolism and resistance to anticancer treatment
2020
How cancer cells remodel lipid metabolism: strategies targeting transcription factors
10.1186/s12944-021-01593-8 · 2021
Lipids and genes: regulatory roles of lipids in RNA expression
10.1002/ctm2.863 · 2022
Lipid metabolism and lipidomics applications in cancer research
10.1007/978-981-33-6785-2_1 · 2021
Hepatocellular carcinoma: a review
10.2147/jhc.s61146 · 2016
Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and management
10.1038/s44276-024-00050-0 · 2024
Lipid alterations in chronic liver disease and liver cancer
2022
Protective effect of alpha-mangostin on thioacetamide-induced liver fibrosis in rats as revealed by morpho-functional analysis
2019
Molecular changes following induction of hepatocellular carcinoma by diethylnitrosamine and thioacetamide, and subsequent treatment with dioscorea membranacea extract
10.7150/ijms.72987 · 2022
Anti-angiogenic and anti-proliferative effects of Benja-ummarit extract in rats with hepatocellular carcinoma
2020
An integrated computational, in vitro and metabolomics approach to the discovery of novel aromatase inhibitors with anti-breast cancer activities
10.1038/s41598-025-24086-5 · 2025
MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation
10.1093/nar/gkae253 · 2024
Sustained epigenetic drug delivery depletes cholesterol-sphingomyelin rafts from resistant breast cancer cells, influencing biophysical characteristics of membrane lipids
10.1021/acs.langmuir.5b02601 · 2015
Liver histology: diagnostic and prognostic features
10.1016/j.cld.2019.09.004 · 2020
Histopathological evaluation of liver fibrosis and cirrhosis regression
10.3350/cmh.2017.0078 · 2017
Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems
10.1038/modpathol.3880119 · 2000
Perinodular arteriolar plexus in liver cirrhosis. Scanning electron microscopy of microvascular casts
10.1111/j.1600-0676.1984.tb00907.x · 1984
Collagen arrangement in space of Disse correlates with fluid flow in normal and cirrhotic rat livers
10.1002/jemt.22460 · 2015
Histopathology of hepatocellular carcinoma
10.3748/wjg.v20.i43.15955 · 2014
Fibrosis-dependent mechanisms of hepatocarcinogenesis
10.1002/hep.25670 · 2012
PNPLA3 genotype, arachidonic acid intake, and unsaturated fat intake influences liver fibrosis in hispanic youth with obesity
10.3390/nu13051621 · 2021
Sandrin L. Liver stiffness: a novel parameter for the diagnosis of liver disease
2010
Control of oxidative stress in hepatocellular carcinoma: helpful or harmful?
10.4254/wjh.v7.i7.968 · 2015
The role of oxidative stress in tumorigenesis and progression
10.3390/cells13050441 · 2024
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
10.1186/s12943-024-02119-3 · 2024
Targeted inhibition of ACLY expression to reverse the resistance of sorafenib in hepatocellular carcinoma
10.7150/jca.52778 · 2022
Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice
10.1186/s12944-021-01567-w · 2021
Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2
10.1016/j.plefa.2003.12.012 · 2004
An updated review of lysophosphatidylcholine metabolism in human diseases
10.3390/ijms20051149 · 2019
Breaking down tumor drug resistance: the link between cell membrane changes and treatment efficacy
10.2478/abmj-2023-0003 · 2023
The interplay between membrane viscosity and ligand-binding receptor kinetics in lipid bilayers
10.1007/s11012-024-01779-1 · 2024
Cytosolic phospholipase A2: targeting cancer through the tumor vasculature
10.1158/1078-0432.ccr-08-1905 · 2009
The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism
10.1038/s41467-023-41462-9 · 2023
Understanding sorafenib-induced ferroptosis and resistance mechanisms: implications for cancer therapy
10.1016/j.ejphar.2023.175913 · 2023
Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis
10.3390/cells12050804 · 2023
Cytosolic phospholipase A₂: physiological function and role in disease
10.1194/jlr.r057588 · 2015
Decreased lncRNA HNF4A-AS1 facilitates resistance to sorafenib-induced ferroptosis of hepatocellular carcinoma by reprogramming lipid metabolism
10.7150/thno.99197 · doi-reference
Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers
10.18632/oncotarget.23494 · doi-reference
LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
10.1186/s12935-021-02130-4 · doi-reference
Aberrant lipid metabolism in hepatocellular carcinoma revealed by liver lipidomics
10.3390/ijms18122550 · doi-reference